From: A systematic approach to the reporting of medically relevant findings from whole genome sequencing
Gene | Nucleotide | Protein | Disease | Classification | Inheritance | Report section | Filter |
---|---|---|---|---|---|---|---|
SPATA7 | c.94 + 2 T > C | p.? | Leber congenital amaurosis | LP | AR | Carrier Risk | LOF |
ERCC5 | c.3238C > T | p.Arg1080X | Xeroderma pigmentosum | LP | AR | Carrier Risk | LOF |
COL7A1 | c.7557 + 1G > T | p.? | Epidermolysis bullosa dystrophica | LP | AR | Carrier Risk | LOF |
C2 | c.841_849 + 19del | p.Val281_Arg283del | C2 deficiency | LP | AR | Carrier Risk | LOF |
MYO7A | c.5648G > A | p.Arg1883Gln | Usher syndrome type I | LP | AR | Carrier Risk | HGMD |
NAGA | c.479C > G | p.Ser160Cys | Alpha-N-acetylgalactosaminidase deficiency | LP | AR | Carrier Risk | HGMD |
KCNQ1 | c.826delT | p.Ser276ProfsX13 | Jervell and Lange-Nielsen syndrome | LP | AR | Carrier Risk | LOF |
LAMA2 | c.5563-2A > G | p.? | Congenital muscular dystrophy type IA | LP | AR | Carrier Risk | LOF |
SP110 | c.877A > T | p.Lys293X | Hepatic veno-occlusive disease with immunodeficiency | LP | AR | Carrier Risk | LOF |
ARSB | c.1450A > G | p.Arg484Gly | Mucopolysaccharidosis type VI | LP | AR | Carrier Risk | HGMD |
BEST1 | c.602 T > C | p.Ile201Thr | Autosomal recessive bestrophinopathy | LP | AR | Carrier Risk | HGMD |
ACOX1 | c.1851delT | p.Gly618AlafsX24 | Peroxisomal acyl-CoA oxidase deficiency | LP | AR | Carrier Risk | LOF |
LIFR | c.2074C > T | p.Arg692X | Stuve-Wiedemann syndrome | LP | AR | Carrier Risk | LOF |
PAH | c.842 + 5G > A | p.? | Phenylketonuria | LP | AR | Carrier Risk | HGMD, LOF |
MMACHC | c.271dupA | p.Arg91LysfsX14 | Methylmalonic aciduria and homocystinuria cblC type | P | AR | Carrier Risk | LOF |
CFTR | c.3846G > A | p.Trp1282X | Cystic fibrosis | P | AR | Carrier Risk | HGMD, LOF |
PFKM | c.237 + 1G > A | p.? | Glycogen storage disease 7 | P | AR | Carrier Risk | HGMD, LOF |
CUBN | c.6928_6934del | p.Glu2310CysfsX3 | Imerslund-Gräsbeck syndrome | P | AR | Carrier Risk | LOF |
DUOX2 | c.3847 + 2 T > C | p.? | Hypothyroidism | P | AR | Carrier Risk | LOF |
ABCA4 | c.5882G > A | p.Gly1961Glu | Stargardt disease | P | AR | Carrier Risk | HGMD |
MPO | c.2031-2A > C | p.? | Myeloperoxidase deficiency | P | AR | Carrier Risk | HGMD |
SERPINA1 | c.1096G > A | p.Glu366Lys | Chronic obstructive pulmonary disease | P | AR | Carrier Risk | HGMD |
USH2A | c.1214del | p. Asn405IlefsX3 | Usher syndrome type II | P | AR | Carrier Risk | LOF |
CLRN1 | c.528 T > G | p.Tyr176X | Usher syndrome type III | P | AR | Carrier Risk | HGMD, LOF |
CYP1B1 | c.171G > A | p.Trp57X | Primary congenital glaucoma | P | AR | Carrier Risk | LOF |
NLRP7 | c.337_338insG | p.Glu113GlyfsX7 | Recurrent hydatidiform mole | P | AR | Carrier Risk | LOF |
BTD | c.1330G > C | p.Asp444His | Biotinidase deficiency | P | AR | Carrier Risk | HGMD |
SPG7 | c.1529C > T | p.Ala510Val | Spastic paraplegia type 7 | P | AR | Carrier Risk | HGMD |
PYGL | c.25_44dup | p.Ser15ArgfsX21 | Glycogen storage disease 6 | P | AR | Carrier Risk | LOF |
WFS1 | c.124C > T | p.Arg42X | Wolfram syndrome | P | AR | Carrier Risk | LOF |
CYP1B1 | c.1103G > A | p.Arg368His | Primary congenital glaucoma | P | AR | Carrier Risk | HGMD |
TCIRG1 | c.1674-1G > A | p.? | Infantile malignant osteopetrosis | P | AR | Carrier Risk | HGMD, LOF |
LTBP4 | c.254delT | p.Leu85ArgfsX15 | Cutis laxa, autosomal recessive, type IC | P | AR | Carrier Risk | LOF |
RAPSN | c.264C > A | p.Asn88Lys | Congenital myasthenic syndrome | P | AR | Carrier Risk | HGMD |
TCTN2 | c.1877 T > A | p.Leu626X | Joubert syndrome | P | AR | Carrier Risk | LOF |
DUOX2 | c.2895_2898del | p.Phe966SerfsX29 | Congenital hypothyroidism | P | AR | Carrier Risk | LOF |
HFE | c.845G > A | p.Cys282Tyr | Hereditary hemochromatosis | P | AR | Carrier Risk | HGMD |
GJB2 | c.109G > A | p.Val37Ile | Hearing loss | P | AR | Carrier Risk | HGMD |
RAB27A | c.259G > C | p.Ala87Pro | Familial hemophagocytic lymphohistiocytosis | VUS:FP | AR | Carrier Risk | HGMD |
CNGA3 | c.1669G > A | p.Gly557Arg | Achromatopsia | VUS:FP | AR | Carrier Risk | HGMD |
KCNQ1 | c.826delT | p.Ser276ProfsX13 | Romano Ward syndrome | LP | AD | Monogenic | LOF |
MYBPC3 | c.3742-3759dup | p.Gly1248_Cys1253dup | Hypertrophic cardiomyopathy | LP | AD | Monogenic | HGMD |
MYBPC3 | c.2827C > T | p.Arg943X | Hypertrophic cardiomyopathy | P | AD | Monogenic | HGMD, LOF |
MYBPC3 | c.772G > A | p.Glu258Lys | Hypertrophic cardiomyopathy | P | AD | Monogenic | HGMD |
LHX4 | c.452-2A > C | p.? | Combined pituitary hormone deficiency | P | AD | Monogenic | LOF |
PTPN11 | c.1403C > T | p.Thr468Met | LEOPARD syndrome | P | AD | Monogenic | HGMD |
PPOX | c.199delC | p.Leu67X | Variegate porphyria | P | AD | Monogenic | HGMD, LOF |
MYH7 | c.1987C > T | p.Arg663Cys | Hypertrophic cardiomyopathy | P | AD | Monogenic | HGMD |
ARSE | c.410G > C | p.Gly137Ala | Chondrodysplasia punctata | VUS:FP | XL | Monogenic | HGMD |